ノシセプチン/オルファニンFQ受容体の構造は,ペプチド模倣の複合体である
Aaron A Thompson1, Wei Liu, Eugene Chun
1Department of Molecular Biology, The Scripps Research Institute, La Jolla, California 92037, USA.
Nature
|May 19, 2012
まとめ
ノシセプチン/オルファニンFQペプチド受容体 (NOP) の結晶構造は,リガンド結合の原子詳細を明らかにする. この構造は,NOPを説明します.
科学分野:
- 構造生物学 構造生物学とは
- 神経科学は神経科学である.
- 薬理学 薬理学とは
背景:
- クラシックなデルタ,カッパ,およびマイクロサブタイプを含むオピオイド受容体は,痛みのシグナル伝達に不可欠です.
- オピオイド受容体ファミリーに属するノシセプチン/オルファニンFQペプチド受容体 (NOP) は,後に特定され,独特の薬理学を示しています.
- NOPは,古典的なオピオイド受容体と配列の類似性を共有しているが,リガンド選択性において有意に異なっている.
研究 の 目的:
- 人間のNOP受容体の結晶構造を決定する.
- NOP受容体におけるリガンド認識と選択性の原子詳細を解明する.
- NOPの独特の薬理学的プロフィールを理解するための構造的基礎を提供すること.
主な方法:
- ヒトのNOPの構造を解明するために,X線結晶学を用いた.
- 構造は,ペプチド模倣抗体である化合物-24 (C-24) と複合的に決定された.
- NOPと古典的なオピオイド受容体 (kappaとmicro) の構造的な違いを比較分析した.
主要な成果:
- 化合物-24との複合体におけるヒトのNOPの結晶構造が決定されました.
- 化合物-24がNOP受容体とどのように相互作用するかの原子の詳細が明らかになった.
- NOPと古典的なオピオイド受容体間のリガンド結合ポケットにおける重要な形状的差異が特定されました.
- これらの構造的変異は,NOPのリガンドに対するユニークな選択性を説明します.
結論:
- NOP-化合物-24の構造は,NOP受容体の機能とリガンドの選択性に関する原子的な洞察を提供します.
- 結合ポケットの構造的な違いは,古典的なオピオイド受容体と比較してNOPの独特の薬理学を説明します.
- この構造的なテンプレートは,新しいNOP受容体リガンドの合理的な設計に価値があります.
さらに関連する動画
09:09Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography
Published on: September 20, 2016
14:02Optimizing the Genetic Incorporation of Chemical Probes into GPCRs for Photo-crosslinking Mapping and Bioorthogonal Chemistry in Live Mammalian Cells
Published on: April 9, 2018
関連する概念動画
Nociception
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain. Thus, pain helps the...
G Protein-coupled Receptors
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Drug-Receptor Interaction: Agonist
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
The Two-State Receptor Model
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
The binding affinity of a drug determines its interaction with one...
Cholinergic Receptors: Nicotinic
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
